The PARADIGM-HF and PARAGON-HF trials demonstrated consistent benefits of sacubitril/valsartan relative to RAS inhibitors in ...

KEY POINTS A 35-year-old woman was admitted to a community hospital for sepsis caused by Streptococcus pyogenes bacteremia, ...

The following is a summary of “Impact of Race on Sacubitril/Valsartan use of HF,” published in the October 2024 issue of Cardiology by Lu et al. There is limited understanding of how self-reported ...

In this week’s View, Dr. Eagle looks at the consequences of discontinuing long-term drug treatment in patients with heart ...

Sacubitril/valsartan significantly reduces NT-proBNP levels in patients with heart failure with reduced ejection fraction (HFrEF) over 3 years, with no significant changes in sST2 and galectin-3.

Your browser does not support the audio element. MG Motor has released the first set of images and details of an all-new ES5 electric SUV. The ES5 will be a global ...

With five product launches in six months, MG certainly isn’t slowing down when it comes to bringing new cars to market. In July this year the SAIC owned brand launched the new 2024 variant of ...

MG published the first photos of the ES5, a fully electric SUV for global markets. The ES5 will replace the MG ZS EV, with a larger footprint and modern technology. The MG4-based SUV is powered by ...

Sacubitril/valsartan may be a better treatment option compared with ACEi/ARBs for patients with malignant hypertension-associated thrombotic microangiopathy. Kidney recovery is better when thrombotic ...

Use of sacubitril/valsartan compared to other RAS inhibitors demonstrated similar benefit across race categories. For all race categories, risk of severe angioedema was low but numerically higher with ...

Strangely enough, only a few brands offer compact mid-range solutions, so the Edge 50 Neo finds a very tight but comfortable niche for itself. This year's Edge 50 Neo is even better. Motorola has ...